Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 12, 2007, Pages 2324-2338

  Cabrera, Sandra ^a   Gaxiola, Miguel ^b   Arreola, José Luis ^b   Ramírez, Remedios ^a   Jara, Paul ^a   D'Armiento, Jeanine ^c   Richards, Thomas ^d   Selman, Moisés ^b   Pardo, Annie ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

IGFBP3; Lung fibrosis; MMPs; TIMPs

Indexed keywords

BLEOMYCIN; CYTOKINE; GELATINASE B; PROLINE; SOMATOMEDIN BINDING PROTEIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; IMMUNOREACTIVITY; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MICROENVIRONMENT; MOLECULAR WEIGHT; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; TRANSGENIC MOUSE; WILD TYPE; ZYMOGRAPHY;

ANIMALS; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; GENE EXPRESSION; HUMANS; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LUNG; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; NEUTROPHILS; PEROXIDASE; PROTEIN ARRAY ANALYSIS; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

MUS; MUS MUSCULUS;

EID: 34748922290     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.06.022     Document Type: Article

References (45)

1. Aston C., Jagirdar J., Lee T.C., Hur T., Hintz R.L., and Rom W.N. Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 151 (1995) 1597-1603
2. Atkinson J.J., and Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 28 (2003) 12-24
3. Betsuyaku T., Fukuda Y., Parks W.C., Shipley J.M., and Senior R.M. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol. 157 (2000) 525-535
4. Bonner J.C., and Brody A.R. Cytokine-binding proteins in the lung. Am. J. Physiol. 268 (1995) L869-L878
5. Cisneros-Lira J., Gaxiola M., Ramos C., Selman M., and Pardo A. Cigarrete smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs. Am. J. Physiol. Lung Cell Mol. Physiol. 285 (2003) L949-L956
6. Folgueras A.R., Pendas A.M., Sanchez L.M., and Lopez-Otin C. Matrix metalloproteinases in cancer: From new functions to improved inhibition strategies. Int. J. Dev. Biol. 48 (2004) 411-424
7. Fowlkes J.L., Enghild J.J., Suzuki K., and Nagase H. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem. 269 (1994) 25742-32574
8. Fukuda Y., Ishizaki M., Kudoh S., Kitaichi M., and Yamanaka N. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab. Invest. 78 (1998) 687-698
9. Garcia-Alvarez J., Ramirez R., Checa M., Nuttall R.K., Sampieri C.L., Edwards D.R., et al. Tissue inhibitor of metalloproteinase-3 is up-regulated by transforming growth factor-beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis. Exp. Lung Res. 32 (2006) 201-214
10. Hayashi T., Stetler-Stevenson W.G., Fleming M.V., Fishback N., Koss M.N., Liotta L.A., et al. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am. J. Pathol. 149 (1996) 1241-1256
11. Hemers E., Duval C., McCaig C., Handley M., Dockray G.J., and Varro A. Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: Implications for epithelial-mesenchymal signaling. Cancer Res. 65 (2005) 7363-7369
12. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinol. Rev. 16 (1995) 3-34
13. Kim K.H., Burkhart K., Chen P., Frevert C.W., Randolph-Habecker J., Hackman R.C., et al. Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice. Am. J. Respir. Cell Mol. Biol. 33 (2005) 271-279
14. Kolb M., Bonniaud P., Galt T., Sime P.J., Kelly M.M., Margetts P.J., et al. Differences in the fibrogenic response after transfer of active transforming growth factor-beta1 gene to lungs of "fibrosis-prone" and "fibrosis-resistant" mouse strains. Am. J. Respir. Cell Mol. Biol. 27 (2002) 141-150
15. Lanone S., Zheng T., Zhu Z., Liu W., Lee C.G., Ma B., et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J. Clin. Invest. 110 (2002) 463-474
16. Lee K.W., and Cohen P. Nuclear effects: Unexpected intracellular actions of insulin-like growth factor binding protein-3. J. Endocrinol. 175 (2002) 33-40
17. Legrand C., Gilles C., Zahm J.M., Polette M., Buisson A.C., Kaplan H., et al. Airway epithelial cell migration dynamics: MMP-9 role in cell-extracellular matrix remodeling. J. Cell Biol. 146 (1999) 517-529
18. Lemaitre V., O'Byrne T.K., Borczuk A.C., Okada Y., Tall A.R., and D'Armiento J. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J. Clin. Invest. 107 (2001) 1227-1234
19. Lemaitre V., O'Byrne T.K., Dalal S.S., Tall A.R., and D'Armiento J.M. Macrophage-specific expression of human collagenase (MMP-1) in transgenic mice. Ann. N.Y. Acad. Sci. 878 (1999) 736-739
20. Lemjabbar H., Gosset P., Lechapt-Zalcman E., Franco-Montoya M.L., Wallaert B., Harf A., et al. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: Effects of steroid and immunosuppressive treatment. Am. J. Respir. Cell Mol. Biol. 20 (1999) 903-913
21. Li Q., Park P.W., Wilson C.L., and Parks W.C. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111 (2002) 635-646
22. Manes S., Llorente M., Lacalle R.A., Gomez-Mouton C., Kremer L., Mira E., et al. The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. J. Biol. Chem. 274 (1999) 6935-6945
23. Mochizuki S., Shimoda M., Shiomi T., Fujii Y., and Okada Y. ADAM28 is activated by MMP-7 (matrilysin-1) and cleaves insulin-like growth factor binding protein-3. Biochem. Biophys. Res. Commun. 315 (2004) 79-84
24. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69 (2006) 562-573
25. Pala L., Giannini S., Rosi E., Cresci B., Scano G., Mohan S., et al. Direct measurement of IGF-I and IGFBP-3 in bronchoalveolar lavage fluid from idiopathic pulmonary fibrosis. J. Endocrinol. Invest. 24 (2001) 856-864
26. Pardo A., Barrios R., Gaxiola M., Segura-Valdez L., Carrillo G., Estrada A., et al. Increase of lung neutrophils and upregulation of neutrophil gelatinase B and collagenase in hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 161 (2000) 1698-1704
27. Pardo A., Ruiz V., Arreola J.L., Ramírez R., Cisneros-Lira J., Gaxiola M., et al. Bleomycin-induced pulmonary fibrosis is attenuated in gamma glutamyl transpeptidase-deficient mice. Am. J. Respir. Crit. Care Med. 167 (2003) 925-932
28. Pardo A., and Selman M. Molecular mechanisms of pulmonary fibrosis. Front. Biosci. 7 (2002) d1743-d1761
29. Pardo A., and Selman M. Matrix metalloproteases in the aberrant fibrotic tissue remodeling. Proc. Am. Thorac. Soc. 3 (2006) 383-388
30. Pérez-Ramos J., Segura L., Ramírez R., Vanda B., Selman M., and Pardo A. Matrix metalloproteinases 2,9 and 13 and tissue inhibitor of metalloproteinases 1 and 2 in early and late lesions of experimental lung silicosis. Am. J. Respir. Crit. Care Med. 160 (1999) 1274-1282
31. Pilewski J.M., Liu L., Henry A.C., Knauer A.V., and Feghali-Bostwick C.A. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am. J. Pathol. 166 (2005) 399-407
32. Ruiz V., Ordonez R.M., Berumen J., Ramirez R., Uhal B., Becerril C., et al. Unbalanced collagenase/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 285 (2003) L1026-L1036
33. Sadowski T., Dietrich S., Koschinsky F., and Sedlacek R. Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3. Mol. Biol. Cell 14 (2003) 4569-4580
34. Schonbeck U., Mach F., and Libby P. Generation of biologically active IL-1b by matrix metalloproteinases: A novel caspase-1-independent pathway of IL-1b processing. J. Immunol. 161 (1998) 3340-3346
35. Selman M., Pardo A., Barrera L., Estrada A., Watson S.R., Wilson K., et al. Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. Am. J. Respir. Crit. Care Med. 173 (2006) 188-198
36. Selman M., Ruiz V., Cabrera S., Segura L., Ramírez R., Barrios R., et al. TIMP -1, -2,-3 and -4 in idiopathic pulmonary fibrosis. A prevailing non degradative lung microenvironment?. Am. J. Physiol. 279 (2000) L562-L574
37. Singh B., Charkowicz D., and Mascarenhas D. Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3. J. Biol. Chem. 279 (2004) 477-487
38. Suga M., Iyonaga K., Okamoto T., Gushima Y., Miyakawa H., Akaike T., et al. Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 162 (2000) 1949-1956
39. Swiderski R.E., Dencoff J.E., Floerchinger C.S., Shapiro S.D., and Hunninghake G.W. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 152 (1998) 821-828
40. Van den Steen P.E., Proost P., Wuyts A., Van Damme J., and Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO- and leaves RANTES and MCP-2 intact. Blood 96 (2000) 2673-2681
41. Van den Steen P.E., Wuyts A., Husson S.J., Proost P., Van Damme J., and Opdenakker G. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270 (2003) 3739-3749
42. Woessner J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch. Biochem. Biophys. 93 (1961) 440-447
43. Yaguchi T., Fukuda Y., Ishizaki M., and Yamanaka N. Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis. Pathol. Int. 48 (1998) 954-963
44. Yasuoka H., Zhou Z., Pilewski J.M., Oury T.D., Choi A.M., and Feghali-Bostwick C.A. Insulin-like growth factor-binding protein-5 induces pulmonary fibrosis and triggers mononuclear cellular infiltration. Am. J. Pathol. 169 (2006) 1633-1642
45. Zuo F., Kaminski N., Eugui E., Allard J., Yakhini Z., Ben-Dor A., et al. Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6292-6297